Chlordiazepoxide Hydrochloride And Clidinium Bromide Capsule
Product Images NDC 60219-1677

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Chlordiazepoxide Hydrochloride And Clidinium Bromide (NDC 60219-1677). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Chlordiazepoxide Hydrochloride And Clidinium Bromi 1)

FDA Label Image

1 (Chlordiazepoxide Hydrochloride And Clidinium Bromi 2)

FDA Label Image

1 (Chlordiazepoxide Hydrochloride And Clidinium Bromi 3)

1 (Chlordiazepoxide Hydrochloride And Clidinium Bromi 3)
This is a medication package for chlordiazepoxide hydrochloride, a prescription drug. Each capsule contains 25mg of H&C Eromide, USP. The usual adult dosage is one or two capsules 3 or 4 times a day, taken before meals and at bedtime. The package insert contains additional dosage recommendations and important prescribing information. The medication should be stored in a tight, light-resistant container at controlled room temperature. This medication is manufactured by Amneal Pharmaceuticals and distributed in Bridgeviater, N 08807. Lot and exp. date information are provided on the package.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.